Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.54 |
| ▸ | PPARG | P37231 | 3/20 | 0.54 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | RXRA | P19793 | 2/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.50 |
| ▸ | F7 | P08709 | 3/20 | 0.50 |
| ▸ | F3 | P13726 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18339353 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL88350 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1245698 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL19920999 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21052414 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL88349 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1245776 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL19921001 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL9155208 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL290480 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CYP19A1PPARGOXER1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107406375-B | Process for producing unsaturated ketone compound | 埃维克辛公司 | 2020-09-15 | — | — | CN | claimed |
| EP-3247700-B1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2019-03-20 | — | — | EP | claimed |
| US-10183911-B2 | Process for the preparation of a polyunsaturated ketone compound | AVEXXIN AS (NO) | 2019-01-22 | — | — | US | claimed |
| US-20180009745-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2018-01-11 | — | — | US | claimed |
| EP-3247700-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | Avexxin AS (NO) | 2017-11-29 | — | — | EP | claimed |
| WO-2016116634-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2016-07-28 | — | — | WO | claimed |
| CN-107406375-B | Process for producing unsaturated ketone compound | 埃维克辛公司 | 2020-09-15 | — | — | CN | disclosed |
| US-20190322620-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2019-10-24 | — | — | US | disclosed |
| US-20190322620-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2019-10-24 | — | — | US | disclosed |
| EP-2427415-B1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | BASF AS (NO) | 2019-03-20 | — | — | EP | disclosed |
| EP-3247700-B1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2019-03-20 | — | — | EP | disclosed |
| EP-3247700-B1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | AVEXXIN AS (NO) | 2019-03-20 | — | — | EP | disclosed |
| US-10183911-B2 | Process for the preparation of a polyunsaturated ketone compound | AVEXXIN AS (NO) | 2019-01-22 | — | — | US | disclosed |
| WO-2010128401-A9 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-12-08 | — | — | WO | disclosed |
| US-20110105781-A1 | Process for the Synthesis of Long-Chain Fatty Acids | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2011-05-05 | — | — | US | disclosed |
| WO-2010128401-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-11 | — | — | WO | disclosed |
| US-20100035990-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-02-11 | — | — | US | disclosed |
| EP-2147910-A1 | Novel lipid compounds | Pronova BioPharma Norge AS (NO) | 2010-01-27 | — | — | EP | disclosed |
| EP-2094640-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | Pronova BioPharma Norge AS (NO) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008053331-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | PRONOVA BIOPHARMA NORGE A/S (SE) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035990-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) | PPARG, PPARA, FFAR3 | ALDH1A1 1088/4885CYP19A1 922/4885PPARG 1/4885 |
| US-20110105781-A1 | Process for the Synthesis of Long-Chain Fatty Acids | FASN, ELOVL1, ACSL1 | ALDH1A1 168/4885CYP19A1 192/4885PPARG 262/4885 |
| US-20180009745-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | GK, GPX4, GLRX3 | ALDH1A1 515/4885CYP19A1 1393/4885PPARG 133/4885 |
| US-20190322620-A1 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | GK, GPX4, SGMS2 | ALDH1A1 458/4885CYP19A1 1380/4885PPARG 145/4885 |
| US-10183911-B2 | Process for the preparation of a polyunsaturated ketone compound | GK, GPX4, GLRX3 | ALDH1A1 515/4885CYP19A1 1393/4885PPARG 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.